Eyenovia strategic partner arctic vision enrolls first patient in phase iii clinical trial of arvn003 (microline) for presbyopia in china

Arctic vision also licensed and is developing eyenovia's programs for pediatric progressive myopia (micropine) and pharmacologic mydriasis (mydcombi™) in greater china and south korea arctic vision also licensed and is developing eyenovia's programs for pediatric progressive myopia (micropine) and pharmacologic mydriasis (mydcombi™) in greater china and south korea
EYEN Ratings Summary
EYEN Quant Ranking